Carlos Pérez-Plascencia

Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors.

A. Dueñas-González, L. Herrera, E. Pérez-Cárdenas, 2008, Cancer treatment reviews.

Three-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research

C. López-Camarillo, L. Marchat, Carlos Pérez-Plascencia, 2022, Frontiers in Oncology.

High prevalence of human papillomavirus and European variants of HPV 16 infecting concomitantly to cervix and oral cavity in HIV positive women

A. García-Carrancá, Carlos Pérez-Plascencia, D. Cantú de León, 2020, PloS one.

Acantholytic squamous cell carcinomas of the cervix: A case series.

D. Prada, Carlos Pérez-Plascencia, D. Cantú de León, 2021, Annals of diagnostic pathology.

Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered

Carlos Pérez-Plascencia, M. Cerbón, M. Rodríguez-Dorantes, 2022, Frontiers in Genetics.

Análisis de expresión global del cáncer cérvico uterino: rutas metabólicas y genes alterados

I. Alvarado, P. Piña-Sánchez, M. Salcedo, 2005 .

SFRP1 induces a stem cell phenotype in prostate cancer cells

Carlos Pérez-Plascencia, K. Vazquez-Santillan, G. Rodríguez-Martínez, 2023, Frontiers in Cell and Developmental Biology.

[Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].

I. Alvarado, G. Vázquez-Ortíz, P. Piña-Sánchez, 2005, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Organotypic 3D Cell-Architecture Impacts the Expression Pattern of miRNAs–mRNAs Network in Breast Cancer SKBR3 Cells

C. López-Camarillo, Carlos Pérez-Plascencia, M. Aguilar-Medina, 2023, Non-coding RNA.